Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism MAP3K14 inhibitors(mitogen-activated protein kinase kinase kinase 14 inhibitors), NRK inhibitors(Nik related kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Discovery | - | 23 Jan 2025 | |
Immune System Diseases | Discovery | - | 23 Jan 2025 | |
Neoplasms | Discovery | - | 23 Jan 2025 | |
Neoplasms | Discovery | - | 23 Jan 2025 | |
Neoplasms | Discovery | - | 23 Jan 2025 | |
Neoplasms | Discovery | - | 23 Jan 2025 | |
Respiratory Diseases | Discovery | - | 23 Jan 2025 | |
Respiratory Diseases | Discovery | - | 23 Jan 2025 | |
Respiratory Diseases | Discovery | - | 23 Jan 2025 | |
Respiratory Diseases | Discovery | - | 23 Jan 2025 |